Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unknown Primary Carcinoma”

125 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 125 results

Early research (Phase 1)Study completedNCT02897375
What this trial is testing

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

Who this might be right for
Solid NeoplasmStage III Pancreatic CancerStage IIIA Breast Cancer+14 more
Emory University 71
Testing effectiveness (Phase 2)Looking for participantsNCT06995508
What this trial is testing

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

Who this might be right for
Cancer-Associated AnorexiaHead and Neck Squamous Cell CarcinomaNeck Squamous Cell Carcinoma of Unknown Primary
Roswell Park Cancer Institute 66
Testing effectiveness (Phase 2)Study completedNCT00193609
What this trial is testing

Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site

Who this might be right for
Neoplasms, Unknown Primary
SCRI Development Innovations, LLC 48
Testing effectiveness (Phase 2)Ended earlyNCT03396471
What this trial is testing

Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary

Who this might be right for
Carcinoma, Unspecified Site
Hoosier Cancer Research Network 14
Testing effectiveness (Phase 2)Ended earlyNCT00201734
What this trial is testing

Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary

Who this might be right for
TumorsUnknown Primary TumorsAdenocarcinoma
Ohio State University Comprehensive Cancer Center 57
Early research (Phase 1)Looking for participantsNCT06868433
What this trial is testing

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more
Emory University
Testing effectiveness (Phase 2)Active Not RecruitingNCT06638931
What this trial is testing

Agnostic Therapy in Rare Solid Tumors

Who this might be right for
Urachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more
Instituto do Cancer do Estado de São Paulo 28
Testing effectiveness (Phase 2)Ended earlyNCT00003526
What this trial is testing

Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin

Who this might be right for
Unknown Primary Carcinoma
Burzynski Research Institute 8
Testing effectiveness (Phase 2)Study completedNCT00936702
What this trial is testing

Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary

Who this might be right for
Carcinoma of Unknown Primary Origin
Alliance for Clinical Trials in Oncology 46
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Very early researchStudy completedNCT03868020
What this trial is testing

Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Squamous Cell Carcinoma in Cervical Lymph Node
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Ended earlyNCT03628079
What this trial is testing

A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.

Who this might be right for
Cancer of the Gastrointestinal TractCancer of Unknown Origin
Repos Pharma 11
Not applicableStudy completedNCT00530283
What this trial is testing

PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy

Who this might be right for
Squamous Cell Cancer
AHS Cancer Control Alberta 20
Not applicableStudy completedNCT02628379
What this trial is testing

Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary

Who this might be right for
Neoplasms, Unknown PrimaryCUPMetastatic Disease+3 more
Foundation Medicine 125
Not applicableActive Not RecruitingNCT05904327
What this trial is testing

Circulating Biomarkers in Oropharyngeal Cancers

Who this might be right for
Oropharynx Squamous Cell CarcinomaOropharynx CancerTonsillar Cancer+1 more
Region Örebro County 130
Testing effectiveness (Phase 2)Looking for participantsNCT05576974
What this trial is testing

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

Who this might be right for
Head and Neck CancerUnknown Primary CancerHead and Neck Squamous Cell Carcinoma
University of Texas Southwestern Medical Center 120
Not applicableLooking for participantsNCT06644716
What this trial is testing

[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin

Who this might be right for
Cancer of Unknown Primary
Erasmus Medical Center 50
Not applicableLooking for participantsNCT04475640
What this trial is testing

Cancer Genetic Testing in Ethnic Populations

Who this might be right for
Breast CarcinomaCarcinoma of Unknown PrimaryCentral Nervous System Carcinoma+8 more
Mayo Clinic 1,800
Large-scale testing (Phase 3)UnknownNCT00022178
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

Who this might be right for
Carcinoma of Unknown Primary
The Christie NHS Foundation Trust
Testing effectiveness (Phase 2)UnknownNCT02590055
What this trial is testing

Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary

Who this might be right for
Carcinoma of Unknown Primary
Samsung Medical Center 29
Load More Results
12